In vivo molecular imaging using engineered affinity reagents and fluorescent laser scanning confocal endomicroscopy

使用工程亲和试剂和荧光激光扫描共焦内窥镜进行体内分子成像

• 批准号: LP100200801
• 负责人: Prof Anthony Kelleher
• 金额: $ 17.34万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-06-30 至 2014-06-29
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP100200801
• 关键词: vivo; molecular; imaging; using; engineered

The goal of this project is to develop laser scanning confocal endomicroscopy as a tool for basic scientific discovery and rapid detection of disease biomarkers. The cutting-edge instrument and associated technologies will provide scientists with unprecedented access to dynamic biological processes as they occur in real-time. In addition, it will enable the development of virtual biopsies and instant diagnosis without the need for costly and time-consuming histopathological reports. Thus, it will not only drive transformative research but also transform health care delivery. It will also be a major boost to the Australian biotechnology industry with potential for enormous economic benefits.

该项目的目标是开发激光扫描共聚焦内窥镜，作为基础科学发现和快速检测疾病生物标志物的工具。这种尖端的仪器和相关技术将为科学家提供前所未有的实时动态生物过程的访问。此外，它将使虚拟活组织检查和即时诊断的开发成为可能，而不需要昂贵和耗时的组织病理学报告。因此，它不仅将推动变革性的研究，还将改变医疗保健的提供。这也将是对澳大利亚生物技术产业的重大推动，具有巨大的经济效益潜力。